Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Cannabis
  • Hyperalgesia
  • Pain
  • Tolerance
Type
Interventional
Phase
Phase 2
Design
Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: This study comprises a 16-day inpatient stay. On the first full inpatient day (Day 1), participants will smoke one specified strength (Dose A) of cannabis. Days 2-8 will comprise Phase 1, in which a second strength (Dose B) of cannabis will be administered 3x/day. The next 7 days (Day 9-15) will be Phase 2, in which cannabis Dose A will be administered once again, at the same 3 daily time points.Masking: None (Open Label)Primary Purpose: Basic Science

Participation Requirements

Age
Between 21 years and 60 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04596644
Collaborators
National Institute on Drug Abuse (NIDA)
Investigators
Not Provided